NCT00255268撤回4 期
Longitudinal, Randomized, Open and Prospective Clinical Trial to Evaluate the Efficacy of Continuous vs Intermittent Maximum Androgen Blockade (CMAB vs IMAB) With Goserelin-Bicalutamide Combination in the Treatment of Hormonal naïve With Metastatic Prostate Cancer
适应症
相关药物
试验速览
- 阶段
- 4 期
- 状态
- 撤回
- 发起方
- AstraZeneca
- 入组人数
- 15
- 试验地点
- 2
- 主要终点
- Time to progression
研究概览
简要总结
To evaluate the efficacy, safety and survival of two treatment regimens: Continuous Intermittent Maximum Androgen Blockade, using goserelin and bicalutamide in patients with prostate cancer. Primary endpoint is time to progression. Fifteen patients will be evaluated. QoL evaluation is also included.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Histological diagnosis of D2 of Adenocarcinoma,
- •Naivety to treatment
- •Valuable bone metastasis
排除标准
- •Hematological, liver or renal toxicity Grade IV
- •Severe and active infections
结局指标
主要结局
Time to progression
次要结局
- Safety
- Quality of Life
研究者
研究点 (2)
Loading locations...
相似试验
已完成
2 期
A 48 Week Study to Evaluate the Efficacy and Safety of Two (2) EYS606 Treatment Regimens in Subjects With Active Chronic Non-infectious Uveitis (CNIU)Non-infectious UveitisNCT04207983Eyevensys3
已完成
3 期
Trial Comparing Infliximab and Infliximab and Azathioprine in the Treatment of Patients With Crohn's Disease na�ve to Both Immunomodulators and Biologic Therapy (Study of Biologic and Immunomodulator Naive Patients in Chrohn's Disease: SONICCrohn DiseaseNCT00094458Centocor Ortho Biotech Services, L.L.C.508
终止
4 期
Ribavirin for Severe Acute and Chronic Hepatitis E Virus Infection.Hepatitis ENCT02558114Hospital Universitari Vall d'Hebron Research Institute5
已完成
3 期
Multicenter, Randomized, Double-Blind, Double-Dummy, Phase 3 Study of the Safety and Efficacy of Elvitegravir Versus RaltegravirHIV InfectionNCT00708162Gilead Sciences724
终止
4 期
A Study Comparing Safety and Efficacy of Levofloxacin and Metronidazole Versus Piperacillin/Tazobactam in Treating Complicated AppendicitisAppendicitisNCT00236912Johnson & Johnson Pharmaceutical Research & Development, L.L.C.139
